baber/WOPTO huggingface dataset:
Patent NZ-596125-A (NZ)
Title: Checkpoint kinase 1 inhibitors for potentiating dna damaging agents
Inventor: HUMPHRIES MICHAEL J
IPC: A61K31/437
Filed: 2010-04-09
Abstract: Disclosed is a Chk1 (Checkpoint kinase-1) inhibitor selected from the group consisting of (R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)nicotinamide; (R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)isobutyramide; (R)-N-(5-bromo-4-(3-(methylamino)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)nicotinamide; (R)-N-(4-(3-aminopiperidin-1-yl)-5- bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-methylnicotinamide; (R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide; (R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1Hpyrrolo[ 2,3-b]pyridin-3-yl)-3-methyl-butanamide; and (R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2- cyclopropylacetamide, for administration to a patient with cancer for potentiating a DNA damaging agent, wherein the administration of the CHK1 inhibitor follows the administration of the DNA damaging agent, wherein the CHK1 inhibitor is administered in two doses, the first dose of the CHK1 inhibitor is administered one day after the DNA damaging agent, and the second dose of the CHK1 inhibitor is administered two days after the DNA damaging agent.
Patent NZ-598716-A (NZ)
Title: Novel enteric combination therapy
Inventor: BORODY THOMAS JULIUS
IPC: A61K31/165
Filed: 2010-10-22
Abstract: There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhoea, chronic idiopathic nausea, IBD-associated constipation and diarrhoea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, Parkinsons disease, MS, Alzheimers Disease, Motor Neurone Disease or autism, the composition comprising: (i) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or ( (ii) at least one anti-clostridial agent selected from the above combined with an opioid blocking agent. There is also disclosed herein a method of treating various gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhoea, chronic idiopathic nausea, IBD-associated constipation and diarrhoea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, Parkinsons disease, MS, Alzheimers Disease, Motor Neurone Disease or autism, the method comprising administering orally, via enema or by suppository: (i) a composition of the invention; (ii) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (iii) at least one anti-clostridial agent selected from the above and an opioid blocking agent to a patient in need of such treatment.
Patent NZ-598785-A (NZ)
Title: Beverage cartridge with particles of filter aid mixed with the beverage particles to reduce backpressure
Inventor: PETERSON PETER
IPC: A47J31/06
Filed: 2010-08-20
Abstract: 598785 A method for forming a beverage comprises providing a cartridge 10 having an internal space 14, providing particles of a dry beverage medium 20 in the internal space 14 of the cartridge 10 where the beverage medium 20 including at least one ingredient that forms a beverage when mixed with a liquid that is introduced into the internal chamber, and providing particles of a dry filter aid 21 with the beverage medium 20 in the internal space 14. The particles of filter aid 21 are mixed with the particles of beverage medium 20 such that the filter aid 21 is arranged to reduce a backpressure in the internal space during flow of liquid in the cartridge 10 by assisting in flow of liquid through the beverage medium 20 or a filter used to remove material from the beverage.
Patent NZ-603332-A (NZ)
Title: Sweet flavor modifier
Inventor: TACHDJIAN CATHERINE
IPC: A23L27/30
Filed: 2011-03-31
Abstract: Disclosed herein are compounds having structural formula (IIIa) or (IIIa’). These compounds are useful as sweet flavour modifiers. The present disclosure also includes compositions comprising the present compounds and methods of enhancing the sweet taste of ingestible compositions. In one embodiment the compound is 1-amino-3-methyl-6b,7,8,9,10,10a-hexahydrobenzofuro[2,3-f]quinoline-2-carboxylic acid.
Patent NZ-610460-A (NZ)
Title: Immunoglobulin cleavage fragments vaccine compositions
Inventor: JORDAN ROBERT
IPC: A61K39/00
Filed: 2010-11-19
Abstract: Disclosed is a use of a peptide immunogen, wherein the peptide is capable of generating antibodies reactive with a proteolytic cleavage site on IgG, in the preparation of a medicament for use in protecting a human subject from a pathological condition characterised by the release of a protease, wherein the pathological condition is a disease selected from an arthritic disease, a malignant disease, the presence of an infectious agent or a parasite, and a vascular disease.
Patent NZ-612426-A (NZ)
Title: Method of forming a containment system for an absorbent article
Inventor: JEFFREY ALAN DEBROUX
IPC: A61F13/47
Filed: 2013-06-24
Abstract: Elastic elements (depicted as the round cords) are bonded near the respective edges of a longitudinal substrate 240 which is then subjected to progressive bonding and edge folding operations and then slit down the middle 246 to form a pair of leakage guards 44, 46. These respective guards are then bonded each along and inwardly of the respective longitudinal side of the absorbent base pad and, in particular, in the region of the ends of the pad but not in the crotch region. The lateral flaps that project from the distal end of the stem portion of the flaps are bonded to the stem portions.
Patent NZ-612924-A (NZ)
Title: Improved stackable structural reactors
Inventor: WHITTENBERGER WILLIAM A
IPC: B01J19/18
Filed: 2012-01-27
Abstract: A reactor comprises a stationary fan 3 arranged on a central rod 11 in a reactor tube. The fan 3 has radial fluid ducts 13a, 13b for directing fluid flow through the reactor. The fluid ducts 13b act to radially guide the fluid flow to contact the reactor tube and promote heat transfer along the reactor tube. The fan 3 has a top surface, a bottom surface and an outer diameter face such that the radial fluid ducts 13a, 13b terminate along the outer diameter face of the fan 3 to form fluid duct openings facing the reactor tube.
Patent NZ-615960-A (NZ)
Title: (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
Inventor: BROWN S DAVID
IPC: C07D413/14
Filed: 2012-03-27
Abstract: The disclosure relates to (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles (figure (I)), and their pharmaceutical compositions, preparation, and use as agents or drugs for treating PI3K-mediated diseases. Example compounds include: 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(pyrrolidin-3-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-lH-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(1-(4’-methoxybiphenyl-2-yl)-2-methylpropan-2-yl)-6-morpholino-1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(1-(2-bromophenyl)-2-methylpropan-2-yl)-6-morpholino-1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-IH-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(naphthalen-2-yl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine, 4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(pyrrolidin-3-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine.
Patent NZ-620988-A (NZ)
Title: Method for purifying recombinant adamts13 and other proteins and compositions thereof
Inventor: MAYER CHRISTA
IPC: C12N9/64
Filed: 2010-08-02
Abstract: 620988 Discloses a method for inactivating lipid-enveloped virus contaminants in a protein solution in the purification of a therapeutic protein composition, the method comprising: providing a protein solution comprising the therapeutic protein, immobilising the protein on a support, subsequently treating the protein (while it remains on the support) with a solvent-detergent mixture comprising a non-ionic detergent and an organic solvent, wherein the treatment results in the reduced formation of aggregates of the protein and lipid-enveloped virus contaminants are inactivated.
Patent NZ-625734-A (NZ)
Title: Process for providing a filled canister for an inhaler
Inventor: FLETCHER IAN MARK
IPC: B65B37/06
Filed: 2011-02-09
Abstract: A process for providing a filled canister (138) for an inhaler with has not been purged prior to filling is disclosed. In particular it is a process for supplying a canister (138) and filling the canister (138) with components of a medicament, which canister (138) is suitable for use in a pressurised metered dose inhaler, preferably a breath-actuate inhaler. The process comprises providing a canister (138) that is substantially filled with air at ambient conditions and sealing the opening of the canister (138), for example with a metering valve (134). A filling device dispenses a pressurised liquid and/or gas into the sealed, air-filled canister (138) through the metering valve (134). The pressurised liquid and/or gas comprises at least a propellant. The sealed, air-filled canister (138) is substantially devoid of propellant prior to the step of dispensing the pressurised liquid and/or gas. Thereafter the sealed canister (138) is substantially filled with at least some propellant and some air. Preferably the sealed canister (138) also contains a medicament. In the art, pressure-filled canisters are purged with propellant immediately before sealing to remove the air. The present process excludes the purging step and the sealed canisters (138) contain air and no propellant prior when sealed which prevents unnecessary release of the propellant into the atmosphere.
Patent NZ-631080-A (NZ)
Title: Protective headdress for use with a safety helmet
Inventor: MICHAEL EVERINGHAM
IPC: A42B3/10
Filed: 2014-09-11
Abstract: A headdress 20 for use with a safety helmet 10, the safety helmet including an outer shell 11, a suspension device 12 and a harness 13, the headdress including a fabric connecting flap 22 configured to releasably attach the headdress 20 to the safety helmet 10. The headdress 20 is configured so that it is wholly located outside the harness 13 when connected to the helmet 10.
Patent NZ-718622-A (NZ)
Title: Multisubstituted aromatic compounds as inhibitors of thrombin
Inventor: WILLIAMS DAVID CHARLES
IPC: C07D409/14
Filed: 2011-03-30
Abstract: Use of a compound with structure of the Formula shown where L1-L4 and R1-R4 are as defined in the specification, which are thrombin inhibitors, for the treatment of a disease or disorder in a subject such as acute coronary syndrome, venous thromboembolism, arterial thromboembolism or cardiogenic thromboembolism.
Patent NZ-719050-A (NZ)
Title: Combination therapy combining a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
Inventor: KIM SUNKYU
IPC: A61P35/00
Filed: 2012-07-02
Abstract: Provided is a combination of a cyclin dependent kinase 4 or cyclin dependent kinase 6 (CDK4/6) inhibitor and a phosphatidylinositol 3-kinase (PI3K) inhibitor useful for the treatment of cancer. A preferred CDK4/6 inhibitor is a compound of Formula A (7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide) (ribociclib). Preferred PI3K inhibitors are the compounds of Formula B1 (5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyrimidinamine) (buparlisib) and Formula B2 ((S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({ 4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl} -amide)) (alpelisib).
Patent NZ-740756-A (NZ)
Title: Nanoparticulate composition containing antibiotics for intramammary administration in animals
Inventor: ARAÚJO RAQUEL SILVA
IPC: A61P31/04
Filed: 2011-06-01
Abstract: Disclosed are two types of polymer nanocapsules to encapsulate cloxacillin benzathine, an antimicrobial drug. Also disclosed are methods of treating mastitis in dairy cattle. More specifically, this disclosure relates to a new form of treatment for mastitis in dairy cattle. Two nanocapsule formulations have been developed and can be used to encapsulate various drugs, besides cloxacillin benzathine, providing a new therapy for mastitis in cows, avoiding the inconvenience of the use of high doses of drugs used in conventional formulations, thus contributing to an improvement in milk quality.
Patent NZ-750379-A (NZ)
Title: Clostridium histolyticum enzymes and methods for the use thereof
Inventor: HERBER WAYNE
IPC: C12N9/52
Filed: 2013-01-10
Abstract: Disclosed is a recombinant nucleic acid molecule comprising a polynucleotide having a sequence of SEQ ID NOs: 1 or 2 or the complement thereof, wherein SEQ ID NOs: 1 and 2 are disclosed within the specification and encode collagenase I and II from Clostridium histolyticum, respectively. Also disclosed is a method for detecting the secretion of a haemolytic toxin from a bacterial production strain, wherein said production strain produces a collagenase, and wherein said method comprises incubating a sample of the bacterial strain with red blood cells under conditions suitable for lysis of the red blood cells by a haemolytic toxin, wherein lysis of the red blood cells indicates secretion of a haemolytic toxin, and wherein the absence of lysis of the red blood cells indicates the absence of a haemolytic toxin.
Patent NZ-757519-A (NZ)
Title: Scalable battery system
Inventor: LEE HEI MAN RAYMOND
IPC: B60L50/64
Filed: 2017-03-31
Abstract: A battery module contains a casing, a cell frame received within and connected to the casing, a first connector mounted to the cell frame; a second connector mounted to the cell frame; and a plurality of sub-modules installed in the cell frame. Each of the plurality of sub-modules includes a plurality of battery cells, the frame cell is detachably fixed to the internal perimeter of the casing. Each of the plurality of sub-modules further contains a positive output terminal and a negative output terminal that are connected to the first connector or the second connector. A plurality of interconnecting features allows the battery module to detachably connect to an adjacent battery module of a same type to form a scalable battery system. Similar battery modules can be stacked to form a battery system with additional capacity, without the need to modify the internal structure or circuit connection of the individual battery module and provide a more secure design that allows easy maintenance to certain parts of a battery module while minimizing the need to affect other components.
Patent NZ-773387-A (NZ)
Title: Coated article including ultra-fast laser treated silver-inclusive layer in low-emissivity thin film coating, and/or method of making the same
Inventor: VEERASAMY VICTOR
IPC: C23C14/58
Filed: 2019-08-01
Abstract: Certain example embodiments relate to ultra-fast laser treatment of silver-inclusive (low-emissivity) low-E coatings, coated articles including such coatings, and/or associated methods. The low-E coating is formed on a substrate (e.g., borosilicate or soda lime silica glass), with the low-E coating including at least one sputter-deposited silver-based layer, and with each said silver-based layer being sandwiched between one or more dielectric layers comprising one or more of zinc, nickel, chromium and titanium. The low-E coating is exposed to laser pulses having a duration of no more than 10-12 seconds, a wavelength of 355-500 nm, and a power density of more than 30 kW/cm2. The exposing is performed so as to avoid increasing temperature of the low-E coating to more than 300 degrees C while also reducing (a) grain boundaries with respect to, and vacancies in, each said silver-based layer, (b) each said silver-based layer’s refractive index, and (c) emissivity of the low-E coating compared to its as-deposited form.
Patent PT-102557-A (PT)
Title: Dried codfish humidifier includes constant water temperature and circulation circuits serving an insulated tank containing fish compartments
Inventor: SOUSA JOAQUIM ROGERIO ALVES DA
IPC: A23L17/00
Filed: 2001-01-23
Abstract: The dried codfish humidifier has a stainless steel cover insulated by foam polyurethane, a water tank (12) of the same material and a bottom block (14) incorporating a water cooling circuit and a water change circuit, maintaining constant temperature and circulation in the tank. The tank houses three removable fish containers.
Patent PT-103935-A (PT)
Title: Máquina e método de ensaio tribológico para a determinação do coeficiente de atrito em interfaces de contacto com superfícies recém-geradas não oxidadas
Inventor: CRISTINO VALENTINO ANOK MELO
IPC: G01N19/02
Filed: 2008-01-18
Abstract: O PRESENTE INVENTO REFERE-SE A UM MÉTODO E RESPECTIVO APARELHO PARA DETERMINAÇÃO DO COEFICIENTE DE ATRITO EM INTERFACES DE CONTACTO ONDE EXISTAM SUPERFÍCIES RECÉM GERADAS, AINDA NÃO OXIDADAS, LIMPAS E QUIMICAMENTE ACTIVAS. ESTE INVENTO É ESPECIALMENTE INDICADO PARA APLICAÇÕES ONDE SE PRETENDAM AVALIAR A INFLUÊNCIA DAS SUPERFÍCIES RECÉM GERADAS, RELATIVAMENTE ÀS OXIDADAS, SENDO UM CASO TÍPICO DA SUA APLICAÇÃO A DETERMINAR DO COEFICIENTE DE ATRITO NOS PROCESSOS TECNOLÔGICOS DE CORTE POR ARRANQUE DE APARA. A MÁQUINA DE ENSAIO TRIBOLÓGICO COMPREENDE UMA MESA QUE SUPORTA A TODA A ESTRUTURA (6), NA QUAL SE ENCONTRA O MOTOR COM VARIADOR DE FREQUÊNCIA (13) PARA O CONTROLO PRECISO DA VELOCIDADE DE ROTAÇÃO DO DISCO (5); UM SUPORTE SOBRE O QUAL ESTÁ MONTADO UM SENSOR DE CARGA BIDIMENSIONAL (9) E O SISTEMA DE FIXAÇÃO DO PROVETE EM FORMA DE PINO (12) QUE É MONTADO NUM SUPORTE (4) DESLIZANTE SOBRE UMA GUIA (8) E O SEU MOVIMENTO CONTROLADO POR UM OUTRO MOTOR (1); UM SISTEMA DE AQUISIÇÃO, CONTROLO E MONITORIZAÇÃO DE DADOS QUE POR SUA VEZ, LIGADO A UM COMPUTADOR PESSOAL.
Patent PT-115479-A (PT)
Title: Sistema de computador e método de operação para gerir dados pessoais anonimizados
Inventor: RICARDO LOURA
IPC: G06F21/00
Filed: 2019-04-29
Abstract: UM SISTEMA E UM MÉTODO SÃO APRESENTADOS PARA PERMITIR QUE OS COMPUTADORES COMUNIQUEM E TRANSMITAM DADOS PESSOAIS NUM SISTEMA SEGURO, ONDE A SEGURANÇA É ALCANÇADA POR UM COMPUTADOR QUE DESIDENTIFICA OS DADOS PESSOAIS ATRAVÉS DA REMOÇÃO DE TODOS OS IDENTIFICADORES PESSOAIS E SUBSEQUENTEMENTE OS RE-IDENTIFICA COM UM IDENTIFICADOR ANÓNIMO, GERADO PELO COMPUTADOR OPERADO PELO TITULAR DOS DADOS. EMBORA OS DADOS PESSOAIS E O TITULAR DOS DADOS SEJAM ANONIMIZADOS, OS COMPUTADORES NO SISTEMA ACTUAL PODEM ESTABELECER UMA SESSÃO DE COMUNICAÇÃO ENTRE O COMPUTADOR DO TITULAR DE DADOS ANÓNIMO E O SISTEMA DE COMPUTADOR QUE POSSUI INFORMAÇÕES DE INTERESSE DO TITULAR DOS DADOS E ENVIAR ESSAS INFORMAÇÕES PARA O SEU TITULAR.
Patent RU-94002511-A (RU)
Inventor: FEDOROV S N
IPC: A61F2/16
Filed: 1994-01-24
Abstract: FIELD: medicine; ophthalmology. SUBSTANCE: artificial crystalline lens has optical and reference elements. Reference element is made in form of two open curvilinear curves, which are directed with their convexities to opposite sides. free distal ends of curves are made for mutual penetration of one into the other one. EFFECT: reduced post- operational complications. 1 cl, 1 dwg
Patent RU-94011877-A (RU)
Inventor: KIKOT I I
IPC: B60J1/10
Filed: 1994-04-05
Abstract: FIELD: development of train coaches, streetcars, motor coach bodies, trolley buses. SUBSTANCE: PASSENGER coach window has a frame of outer and inner parts and panes secured in the window aperture. The panes are installed in seals placed between frame parts. The frame is made of wooden bars and secured between coach bead forming window aperture and interior facing of the coach using screws, brackets and U-shaped section. The seal is closed over perimeter of frame outer part and has three grooves to insert the panes and bead in them. As this takes place, the bead is bent in its upper portion at the angle of 45 degrees to the plane of coach wall. Straight end of the bead is inserted in seal groove for the length of not more than 30 % of seal height. The seal is made of rubber. EFFECT: moisture proof window. 2 cl
Patent RU-94019620-A (RU)
Inventor: BUKHARIN V A
IPC: A61L27/00
Filed: 1994-05-26
Abstract: FIELD: medicine, cardiovascular surgery. SUBSTANCE: used material is Glisson capsule of fresh slaughtered cattle that is used as biological material for prosthesis making. EFFECT: improved quality of prosthesis.
Patent RU-94029274-A (RU)
Inventor: RUDAKOVA T V
IPC: C07C333/20
Filed: 1994-08-03
Abstract: FIELD: chemical technology, organic chemistry. SUBSTANCE: product: compound of the formula RR-C(S)-SCHCHC≡N where Rand R- H, lower C-C-alkyls. Method is based on the reaction interaction of carbon disulfide and corresponding amine excess followed by treatment of formed alkylammonium dithiocarbamate with acrylonitrile. Method ensures to exclude alkali use at the first stage and acetic acid - at the second one that provides this method as wasteless one. Method is used for synthesis of reagent-collectors for flotation concentration of nonferrous metal ores. EFFECT: improved method of synthesis.
Patent RU-94037399-A (RU)
Inventor: BELOV I A
IPC: C01B3/00
Filed: 1994-09-29
Abstract: FIELD: nuclear and hydrogen power engineering. SUBSTANCE: invention consists in that water is subjected to combined action of ultrasound and ionizing irradiation accompanied with addition to water of finely divided particles. EFFECT: at least five-fold increase in hydrogen yield. 7 cl
Patent RU-94041533-A (RU)
Inventor: JAKIMOVICH K A
IPC: F22B1/24
Filed: 1994-11-17
Abstract: FIELD: power-plant mechanical engineering; boiler engineering. SUBSTANCE: steam boiler with turbocharge set has flue divided into two parts, each formed by its own heat-transfer surface made in the form of hollow-wall cylinders accommodating spiral channels for passing heated medium; cylinders are intercommunicating and coaxially arranged relative to each other with clearance between them forming mentioned flue. Heat-transfer surfaces of different flue parts communicate in respect to heated medium. Air is charged into burner assembly by means of turbocompressor whose turbine is connected to gas channel between first and second parts of steam boiler. Combustion products are cooled down in first part of flue to 850-970 K; total pressure drop in flues of first and second parts is maintained between 0.01 and 0.06 MPa; air is compressed to 0.16-0.35 MPa. EFFECT: reduced size and mass, improved economic efficiency and operating reliability of boiler.
Patent RU-94043033-A (RU)
Inventor: TRIFONOV E I
IPC: A61K35/78
Filed: 1994-12-06
Abstract: FIELD: medicine, therapy. SUBSTANCE: method involves administration of preparation "Apimicroelfit" to patient by the definite schedule. Preparation shows correcting and modulating action of organism protective force. EFFECT: enhanced curative action of preparation.